EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”

Cardiovascular Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/cdr/9810149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 13.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/9810149

Vancouver

Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/9810149

BibTeX
@article{euvimed2026,
  title = {Correction to “Asprosin Protects H9C2 Cells From Ferroptosis Following Hypoxia/Reoxygenation by Promoting Mitophagy”},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cdr/9810149}
}
Kostenlos starten →